Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Lanthier

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Clinics and Research in Hepatology and Gastroenterology|August 11, 2023
Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short reviewColin Dumont, Nicolas Lanthier, Géraldine Dahlqvist
Clinics and Research in Hepatology and Gastroenterology|March 5, 2021
Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?Nicolas Lanthier, Peter Stärkel, Géraldine Dahlqvist
Current Opinion in Clinical Nutrition and Metabolic Care|May 29, 2009
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosisNicolas Lanthier, Yves Horsmans, Isabelle A Leclercq
Clinical Science (London, England : 1979)|September 12, 2015
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndromeLaurence Poekes, Nicolas Lanthier, Isabelle A Leclercq
Acta Gastro-Enterologica Belgica|May 9, 2013
Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseasesNicolas Lanthier, Laura Rubbia-Brandt, Laurent Spahr
World Journal of Gastroenterology|November 10, 2022
Improving the prognosis before and after liver transplantation: Is muscle a game changer?Alexis Goffaux, Alicia Delorme, Géraldine Dahlqvist, et al.
Discovery Medicine|June 26, 2024
Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNathan Boliaki, Guillaume Henin, Georgia Bale, et al.
Journal of Clinical and Translational Hepatology|September 18, 2023
A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes PatientsQuentin Binet, Audrey Loumaye, Michel P Hermans, et al.
JHEP Reports : Innovation in Hepatology|February 7, 2024
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver diseaseGuillaume Henin, Audrey Loumaye, Isabelle A Leclercq, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|June 21, 2019
Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions?Christelle Knudsen, Audrey M Neyrinck, Nicolas Lanthier, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Clinics and Research in Hepatology and Gastroenterology|August 11, 2023
Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short reviewColin Dumont, Nicolas Lanthier, Géraldine Dahlqvist
Clinics and Research in Hepatology and Gastroenterology|March 5, 2021
Frailty, sarcopenia and mortality in cirrhosis: what is the best assessment, how to interpret the data correctly and what interventions are possible?Nicolas Lanthier, Peter Stärkel, Géraldine Dahlqvist
Current Opinion in Clinical Nutrition and Metabolic Care|May 29, 2009
The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosisNicolas Lanthier, Yves Horsmans, Isabelle A Leclercq
Clinical Science (London, England : 1979)|September 12, 2015
Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndromeLaurence Poekes, Nicolas Lanthier, Isabelle A Leclercq
Acta Gastro-Enterologica Belgica|May 9, 2013
Liver progenitor cells and therapeutic potential of stem cells in human chronic liver diseasesNicolas Lanthier, Laura Rubbia-Brandt, Laurent Spahr
World Journal of Gastroenterology|November 10, 2022
Improving the prognosis before and after liver transplantation: Is muscle a game changer?Alexis Goffaux, Alicia Delorme, Géraldine Dahlqvist, et al.
Discovery Medicine|June 26, 2024
Impact of Peroxisome Proliferator-Activated Receptor Agonists on Myosteatosis in the Context of Metabolic Dysfunction-Associated Steatotic Liver DiseaseNathan Boliaki, Guillaume Henin, Georgia Bale, et al.
Journal of Clinical and Translational Hepatology|September 18, 2023
A Cross-sectional Real-life Study of the Prevalence, Severity, and Determinants of Metabolic Dysfunction-associated Fatty Liver Disease in Type 2 Diabetes PatientsQuentin Binet, Audrey Loumaye, Michel P Hermans, et al.
JHEP Reports : Innovation in Hepatology|February 7, 2024
Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver diseaseGuillaume Henin, Audrey Loumaye, Isabelle A Leclercq, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|June 21, 2019
Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions?Christelle Knudsen, Audrey M Neyrinck, Nicolas Lanthier, et al.
Pageof 8